Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.avsg.2021.04.008 http://scihub22266oqcxt.onion/10.1016/j.avsg.2021.04.008 33905848!8124015!33905848     free     free     free Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Ann+Vasc+Surg 2021 ; 75 (ä): 120-127 Nephropedia Template TP {{tp|p=33905848|t=2021. Dissecting the Management and Outcomes of Thoracic Aortovascular Disease During the COVID-19 Pandemic |pdf=|usr=}}{{33905848}} gab.com Text Dissecting the Management and Outcomes of Thoracic Aortovascular Disease During the COVID-19 Pandemic JO: Ann Vasc Surg http://www.kidney.de/pget.php?&tw=1&pmid=33905848 #FOAvip OBJECTIVE: The COVID-19 pandemic has forced the cancellation of planned surgery and led to significant surgical service reductions. Early intervention in aortovascular disease is often critical and cannot be deferred despite these reductions. There is urgent need to evaluate the provision and outcomes of thoracic aortovascular intervention during the peak of the pandemic. METHODS: Prospective data was collected for patients receiving open and endovascular thoracic aortovascular intervention over two-time points; January-May 2020 and January-May 2019 at three tertiary cardiovascular centres. Baseline demographics, cardiovascular risk and COVID-19 screening results were noted. Primary outcomes were median length of intensive care unit and hospital stay, intra-operative mortality, 30-day mortality, post-operative stroke, and spinal cord injury. RESULTS: Patients operated in 2020 (41) had significantly higher median EuroSCORE II than 2019 (53) (7.44 vs. 5.86, P?=?0.032) and rates of previous cardiac (19.5% vs. 3.8%, P?=?0.019), aortic (14.6% vs. 1.9%, P?=?0.041), and endovascular (22.0% vs. 3.8%, P?=?0.009) intervention. There was an increase in proportion of urgent cases in 2020 (31.7% vs. 18.9%). There were no intra-operative deaths in 2020 and 1 in 2019 (P?=?1.00). There were no significant differences (P >/= 0.05) in 30-day mortality (4.9% vs. 13.2%), median intensive care unit length of stay (72 vs. 70 hr), median hospital length of stay (8 vs. 9 days), post-operative stroke (3 vs. 6), or spinal cord injury (2 vs. 1) between 2020 and 2019 respectively. CONCLUSIONS: Despite the increased mortality risk of patients and urgency of cases during COVID-19, complicated by the introduction of cohorting and screening regimens, thoracic aortovascular intervention remained safe with comparable in outcomes to pre-COVID-19. Twit Text FOAVip Dissecting the Management and Outcomes of Thoracic Aortovascular Disease During the COVID-19 Pandemic ????Ann Vasc Surg http://www.kidney.de/pget.php?&tw=1&pmid=33905848 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33905848 #FOAvip English Wikipedia <ref>{{Cite pmid|33905848}}</ref> Dissecting the Management and Outcomes of Thoracic Aortovascular Disease During the COVID-19 Pandemic #MMPMID33905848 McPherson I; Chilvers N; Freystaetter K; Sivaharan A; Kanani M; Williams R; McCaslin J; Nandhra S; Booth K Ann Vasc Surg 2021[Aug]; 75 (ä): 120-127 PMID33905848show ga OBJECTIVE: The COVID-19 pandemic has forced the cancellation of planned surgery and led to significant surgical service reductions. Early intervention in aortovascular disease is often critical and cannot be deferred despite these reductions. There is urgent need to evaluate the provision and outcomes of thoracic aortovascular intervention during the peak of the pandemic. METHODS: Prospective data was collected for patients receiving open and endovascular thoracic aortovascular intervention over two-time points; January-May 2020 and January-May 2019 at three tertiary cardiovascular centres. Baseline demographics, cardiovascular risk and COVID-19 screening results were noted. Primary outcomes were median length of intensive care unit and hospital stay, intra-operative mortality, 30-day mortality, post-operative stroke, and spinal cord injury. RESULTS: Patients operated in 2020 (41) had significantly higher median EuroSCORE II than 2019 (53) (7.44 vs. 5.86, P?=?0.032) and rates of previous cardiac (19.5% vs. 3.8%, P?=?0.019), aortic (14.6% vs. 1.9%, P?=?0.041), and endovascular (22.0% vs. 3.8%, P?=?0.009) intervention. There was an increase in proportion of urgent cases in 2020 (31.7% vs. 18.9%). There were no intra-operative deaths in 2020 and 1 in 2019 (P?=?1.00). There were no significant differences (P >/= 0.05) in 30-day mortality (4.9% vs. 13.2%), median intensive care unit length of stay (72 vs. 70 hr), median hospital length of stay (8 vs. 9 days), post-operative stroke (3 vs. 6), or spinal cord injury (2 vs. 1) between 2020 and 2019 respectively. CONCLUSIONS: Despite the increased mortality risk of patients and urgency of cases during COVID-19, complicated by the introduction of cohorting and screening regimens, thoracic aortovascular intervention remained safe with comparable in outcomes to pre-COVID-19. |*COVID-19/diagnosis/mortality/prevention & control/transmission[MESH] |*Vascular Surgical Procedures/adverse effects/mortality[MESH] |Aged[MESH] |Aged, 80 and over[MESH] |Aorta, Thoracic/diagnostic imaging/*surgery[MESH] |Aortic Diseases/diagnostic imaging/mortality/*surgery[MESH] |COVID-19 Testing[MESH] |Databases, Factual[MESH] |England[MESH] |Female[MESH] |Hospital Mortality[MESH] |Humans[MESH] |Length of Stay[MESH] |Male[MESH] |Middle Aged[MESH] |Patient Safety[MESH] |Postoperative Complications/etiology[MESH] |Prospective Studies[MESH] |Risk Assessment[MESH] |Risk Factors[MESH] |Time Factors[MESH]Dissecting the Management and Outcomes of Thoracic Aortovascular Disea(epmc).pdf DeepDyve Pubget Overpricing